These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7888679)

  • 21. p53 mutation and MDM2 amplification are rare even in human papillomavirus-negative cervical carcinomas.
    Ikenberg H; Matthay K; Schmitt B; Bauknecht T; Kiechle-Schwarz M; Göppinger A; Pfleiderer A
    Cancer; 1995 Jul; 76(1):57-66. PubMed ID: 8630877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular expression of MDM2 and p53 in childhood leukemias with poor prognosis.
    Gustafsson B; Christenson B; Hjalmar V; Winiarski J
    Med Pediatr Oncol; 2000 Feb; 34(2):117-24. PubMed ID: 10657873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations of the p53, Rb and MDM2 genes in osteosarcoma.
    Miller CW; Aslo A; Won A; Tan M; Lampkin B; Koeffler HP
    J Cancer Res Clin Oncol; 1996; 122(9):559-65. PubMed ID: 8781571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MDM2 gene amplification and transcript levels in human sarcomas: relationship to TP53 gene status.
    Flørenes VA; Maelandsmo GM; Forus A; Andreassen A; Myklebost O; Fodstad O
    J Natl Cancer Inst; 1994 Sep; 86(17):1297-302. PubMed ID: 8064888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PTEN reverses MDM2-mediated chemotherapy resistance by interacting with p53 in acute lymphoblastic leukemia cells.
    Zhou M; Gu L; Findley HW; Jiang R; Woods WG
    Cancer Res; 2003 Oct; 63(19):6357-62. PubMed ID: 14559824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p21WAF1/CIP1 and MDM2 expression in non-Hodgkin's lymphoma and their relationship to p53 status: a p53+, MDM2-, p21-immunophenotype associated with missense p53 mutations.
    Villuendas R; Pezzella F; Gatter K; Algara P; Sánchez-Beato M; Martínez P; Martínez JC; Muñoz K; García P; Sánchez L; Kocialkowsky S; Campo E; Orradre JL; Piris MA
    J Pathol; 1997 Jan; 181(1):51-61. PubMed ID: 9072003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of the p53 and MDM-2 gene in acute myeloid leukemia.
    Seliger B; Papadileris S; Vogel D; Hess G; Brendel C; Störkel S; Ortel J; Kolbe K; Huber C; Huhn D; Neubauer A
    Eur J Haematol; 1996 Sep; 57(3):230-40. PubMed ID: 8898928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and prognostic significance of murine double minute protein-2 overexpression and P53 gene mutations in childhood acute lymphoblastic leukemia.
    Hendy OM; Elghannam DM; El-Sharnouby JA; Goda EF; El-Ashry R; Al-Tonbary Y
    Egypt J Immunol; 2008; 15(1):93-100. PubMed ID: 20306673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Regulation of NF-kappaB/P65 by MDM2 in acute lymphoblastic leukemia in childhood].
    Hu Q; Zhou MX; Liu SY; Zhang LQ; Liu AQ; Guo YJ; Song Y
    Zhonghua Er Ke Za Zhi; 2003 Dec; 41(12):921-4. PubMed ID: 14723816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The MDM2 oncogene overexpression in chronic lymphocytic leukemia and low-grade lymphoma of B-cell origin.
    Watanabe T; Hotta T; Ichikawa A; Kinoshita T; Nagai H; Uchida T; Murate T; Saito H
    Blood; 1994 Nov; 84(9):3158-65. PubMed ID: 7949188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MDM2 amplification and loss of heterozygosity at Rb and p53 genes: no simultaneous alterations in the oncogenesis of liposarcomas.
    Schneider-Stock R; Walter H; Radig K; Rys J; Bosse A; Kuhnen C; Hoang-Vu C; Roessner A
    J Cancer Res Clin Oncol; 1998; 124(10):532-40. PubMed ID: 9829856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of MDM2, due to enhanced translation, results in inactivation of wild-type p53 in Burkitt's lymphoma cells.
    Capoulade C; Bressac-de Paillerets B; Lefrère I; Ronsin M; Feunteun J; Tursz T; Wiels J
    Oncogene; 1998 Mar; 16(12):1603-10. PubMed ID: 9569028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. P53 and MDM2 co-expression in tobacco and betel chewing-associated oral squamous cell carcinomas.
    Shwe M; Chiguchi G; Yamada S; Nakajima T; Maung KK; Takagi M; Amagasa T; Tsuchida N
    J Med Dent Sci; 2001 Dec; 48(4):113-9. PubMed ID: 12160248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p14ARF homozygous deletion or MDM2 overexpression in Burkitt lymphoma lines carrying wild type p53.
    Lindström MS; Klangby U; Wiman KG
    Oncogene; 2001 Apr; 20(17):2171-7. PubMed ID: 11360201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p53 stabilization and functional impairment in the absence of genetic mutation or the alteration of the p14(ARF)-MDM2 loop in ex vivo and cultured adult T-cell leukemia/lymphoma cells.
    Takemoto S; Trovato R; Cereseto A; Nicot C; Kislyakova T; Casareto L; Waldmann T; Torelli G; Franchini G
    Blood; 2000 Jun; 95(12):3939-44. PubMed ID: 10845931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p53 and mdm2 in mantle cell lymphoma in leukemic phase.
    Solenthaler M; Matutes E; Brito-Babapulle V; Morilla R; Catovsky D
    Haematologica; 2002 Nov; 87(11):1141-50. PubMed ID: 12414343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequency and prognostic significance of murine double minute protein-2 overexpression and p53 gene mutations in childhood acute lymphoblastic leukemia.
    Hendy OM; Elghannam DM; El-Sharnouby JA; Goda EF; El-Ashry R; Al-Tonbary Y
    Hematology; 2009 Dec; 14(6):335-40. PubMed ID: 19941740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MDM2 and p53 in childhood acute lymphoblastic leukemia: higher expression in childhood leukemias with poor prognosis compared to long-term survivors.
    Gustafsson B; Axelsson B; Gustafsson B; Christensson B; Winiarski J
    Pediatr Hematol Oncol; 2001 Dec; 18(8):497-508. PubMed ID: 11764099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Study on MDM2 and p53 gene proteins expression on acute leukemic cells and its correlation with chemotherapeutic efficacy].
    Lin M; Liu Y; Jin J
    Zhonghua Xue Ye Xue Za Zhi; 1998 Jul; 19(7):350-2. PubMed ID: 11189516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.